ZLAB 8-K 2026-11-05
Zai Lab Ltd (ZLAB) 8-K dated 2026-11-05 — accession 0001628280-26-070517.
Zai Lab Ltd (ZLAB) is a biotechnology company listed on NASDAQ.
ZLAB revenue $108.2M
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported ZLAB revenue for 2025-12-31 was $460.2M. Net income was -$175.5M. Revenue was up 15.3% from 2024-12-31 to 2025-12-31. ZLAB currently screens at market cap $2.02B.
Not investment advice. The ZLAB SEC hub lists recent forms. The stock page is the research view.
- Revenue
- $108.2M
- Guidance
- guidance, including with respect to our capital allocation and investment strategy and our expected path to profitability. All s
Why it matters
- guidance, including with respect to our capital allocation and investment strategy and our expected path to profitability. All s
- We are approaching a defining period for Zai Lab, as we advance toward bringing our first internally developed innovative medicines to patients globally,…